期刊文献+

HPLC法同时测定FT-CS胶囊中4种有效成分的含量 被引量:7

Content determination of four components in FT-CS capsules by HPLC
原文传递
导出
摘要 目的建立同时测定Tegafur-Venenum Bufonis(FT—CS)胶囊中4种有效成分含量的方法,提高制剂的质量控制标准。方法采用HPLC法。色谱柱:LunaPhenyl-Hexyl柱(250mm×4.6mm,5μm);流动相:甲醇-水(体积比60:40);流速:1.0mL·min-1;柱温:40℃;检测波长:296nm;进样量:10μL。结果蟾毒灵、脂蟾毒配基、华蟾毒精、替加氟能够达到基线分离;蟾毒灵质量浓度在1.1~21.0mg·L^-1内、脂蟾毒配基质量浓度在2.2—44.0mg·L“内、华蟾毒精质量浓度在2.0~40.0mg·L^-1内、替加氟质量浓度在10.0—40.0mg·L^-1内与峰面积呈良好的线性关系;蟾毒灵、脂蟾毒配基、华蟾毒精、替加氟的回收率分别为98.05%、99.92%、100.02%、101.56%,RSD分别为2.52%、1.19%、0.43%、1.74%。结论该方法可作为FF-CS胶囊的质量控制方法之一。 Objective To establish an HPLC method for the determination of the contents of Tegafur-Venenum Bufonis(FT-CS) capsules. Methods The separation was performed with a Luna Phenyl-Hexyl column (250 mm × 4.6 mm, 5μm), and the mobile phase was CH3OH-H2O ( V: V = 60: 40 ) with a flow rate of 1.0 mL. min^- 1 and temperature was about 40 ℃, the wavelength of the detector was set at 296 nm and the injection volume was 10 μL. Results The average recovery of bufalin, resibufogenin, cinobufagin and tegafur were 98.05% ,99.92%, 100.02% and 101.56%, with RSD of 2.52%, 1.19% ,0.43% and 1.74% ,respectively. The calibration curve were linear throughout the range of 1. 1 - 21. 0 mg. L^-1, 2. 2 - 44.0 mg.L^-1,2.0-40.0 mg.L^-1 and 10.0-40.0 mg.L^-1 ,respectively. Conclusions This method is applicable for the determination of content of FT-CS capsules.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2009年第2期123-126,共4页 Journal of Shenyang Pharmaceutical University
关键词 高效液相色谱法 FT—CS胶囊 替加氟 蟾毒灵 脂蟾毒配基 华蟾毒精 HPLC Tegafur-Venenum Bufonis(FT-CS) capsule tegafur bufalin resibugogenin cinobufagin
  • 相关文献

参考文献7

  • 1ZANG L, NAKAYA K, YOSHIDA T. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like ceils and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers [J]. Cancer Res, 1992,52 (17) :4634 - 4641.
  • 2李艳荣,刘云鹏.蟾蜍毒素的抗肿瘤作用[J].国外医学(中医中药分册),2002,24(3):152-155. 被引量:11
  • 3左小东,崔永安,王锦鸿,秦叔逵,陈惠英.华蟾素对MGC-80-3细胞生长及凋亡影响的实验研究[J].临床肿瘤学杂志,2003,8(1):33-35. 被引量:19
  • 4KATO H, ICHINOSE Y, OHTA M. A randomized trial of adjuvant chemotherapy with Uracil-Tegafur for adenocarcinoma of the lung[J]. New England Journal of Medicine ,2004,350 ( 17 ) : 1713 - 1721.
  • 5ISHIKAWA T, ICHIDA T, SUGITANI S. Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma[ J]. Journal of Gastroenterology and Hepatology,2001,16(4) :452 -459.
  • 6胡定学,陈容艳,雷妍玮,张丽.奥沙利铂联合替加氟持续静脉注射治疗晚期胃癌临床观察[J].肿瘤防治研究,2007,34(11):871-872. 被引量:6
  • 7国家药典委员会.中华人民共和国药典[M].北京:化学工业出版社,2005.114.

二级参考文献10

共引文献769

同被引文献1980

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部